» Articles » PMID: 11324699

Lysophosphatidic Acid Synthesis and Release

Overview
Date 2001 Apr 28
PMID 11324699
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Lysophosphatidic acid (LPA) is a bioactive phospholipid controlling numerous cellular responses through the activation of specific G-protein coupled transmembrane receptors. LPA is present in several biological fluids (serum, plasma, aqueous humor) and can be secreted by several cell types (platelets, fibroblasts, adipocytes, cancer cells). Whereas, multiple pathways of synthesis and degradation of LPA have been described, their relative contribution in extracellular secretion and biodisponibility is still a matter of debate. The first part of the present review is devoted to the description of the different enzymes involved in LPA synthesis (acyltransferases, phospholipases, kinases) and degradation (lysophospholipases, lipid-phosphatases), as well as to the molecules involved in LPA transport (albumin, fatty acid binding proteins, gelsolin, lipoproteins). In a second part, the different physio-pathological situations (aggregation, cancer, injuries) associated with LPA production, as well as the potential role played by LPA in genesis of certain diseases (cancer, obesity, arteriosclerosis) are listed and analyzed.

Citing Articles

Deficiency of lysophosphatidic acid receptor 3 decreases erythropoietin production in hypoxic mouse kidneys.

Yin N, Li X, Zhang D, Qu M, Pei S, Chen X Lipids Health Dis. 2024; 23(1):381.

PMID: 39558335 PMC: 11572133. DOI: 10.1186/s12944-024-02367-8.


The role of YAP/TAZ mechanosignaling in trabecular meshwork and Schlemm's canal cell dysfunction.

Ghosh R, Herberg S Vision Res. 2024; 224:108477.

PMID: 39208753 PMC: 11470804. DOI: 10.1016/j.visres.2024.108477.


Lysophosphatidic Acid Receptors LPAR5 and LPAR2 Inversely Control Hydroxychloroquine-Evoked Itch and Scratching in Mice.

Fischer C, Schreiber Y, Nitsch R, Vogt J, Thomas D, Geisslinger G Int J Mol Sci. 2024; 25(15).

PMID: 39125747 PMC: 11312285. DOI: 10.3390/ijms25158177.


Mechanisms by which obesity regulates inflammation and anti-tumor immunity in cancer.

Miracle C, McCallister C, Egleton R, Salisbury T Biochem Biophys Res Commun. 2024; 733:150437.

PMID: 39074412 PMC: 11455618. DOI: 10.1016/j.bbrc.2024.150437.


Mice deficient in the phosphatase activity of sEH show decreased levels of the endocannabinoid 2-AG in the olfactory bulb and depressive-like behavior.

Oguro A, Kaga Y, Sato H, Fujiyama T, Fujimoto S, Nagai S FEBS Lett. 2024; 598(24):2980-2994.

PMID: 39034140 PMC: 11666072. DOI: 10.1002/1873-3468.14984.